Fragmentation characteristics of glycopeptides by Vékey, Károly et al.
1 
 
INTERNATIONAL JOURNAL OF MASS SPECTROMETRY 345-347: pp. 71-79. (2013) 
http://dx.doi.org/10.1016/j.ijms.2012.08.031 
Corresponding author: László Drahos (drahos.laszlo@ttk.mta.hu). 
 
 
Fragmentation characteristics of glycopeptides 
Károly Vékey, Oliver Ozohanics, Eszter Tóth, Anita Jekő, Ágnes Révész, Judit Krenyácz and László 
Drahos 
 
Institute of Organic Chemistry, Research Centre for Natural Sciences, Hungarian Academy of Sciences, 
Budapest, Pusztaszeri ut 59-67, Hungary 
ABSTRACT 
Mass spectrometric analysis of glycopeptides is an emerging strategy for analysis of glycosylation 
patterns. Here we present an approach using energy resolved collision induced decomposition 
(CID) spectra to determine structural features of glycopeptides. Fragmentation of multiply 
protonated glycopeptides proceeds by a series of competing charge separation processes by 
cleavage of a glycosidic bond, each producing two charged products: a singly charged, “B” type 
sugar (oxonium) ion, and a complementary high mass fragment. Energy requirements (activation 
energies) of these processes are similar to each other, and are far less, than that required for 
peptide fragmentation. At higher collision energies these first generation products fragment 
further, yielding a complex fragmentation pattern. Analysis of low energy spectra (those 
corresponding to ca. 50% survival yield) are straightforward; the ions observed correspond to 
structural features present in the oligosaccharide, and are not complicated by consecutive 
reactions. This makes it feasible to identify and distinguish antenna- and core-fucosylated isomers; 
antenna fucosylation usually suggests presence of the Lewis-X antigen. In general, analysis of the 
triply protonated molecules are most advantageous, where neutral losses and monosaccharide 
oxonium ion formation are less abundant.  
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Highlights 
 
 We present energy resolved CID spectra and fragmentation characteristics of glycopeptides   
 We suggest that glycopeptide analysis should be performed at low energy (SY50) to 
maximize information content 
 Possibility to determine fucosylation site based on MS/MS 
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1) Introduction 
 
K.R. Jennings has been in the forefront of mass spectrometric research for several decades. In the 
90’s his interest turned to biological applications; including study of peptides and proteins. Beside 
research he took education seriously. I remember his excellent lectures and exercises on peptide 
fragmentation at a NATO conference in 2001 [1]. These were not only academically sound, but 
excellent teaching material as well. Although I had a fairly clear understanding of peptide 
fragmentation, I learnt a lot from these. He was kind enough to give me his overheads, which I still 
use in my own teaching. The present communication extends our knowledge of peptide 
fragmentation to glycopeptides. Following the steps of Keith I hope this will not only extend our 
understanding, but will also illustrate general concepts in a didactic manner.  
 
Glycosylation is among the most important and common post-translational protein modifications 
(PTM) [2-4]. A given glycoprotein usually has a large number of glycoforms, having the same 
amino acid backbone, but differing in sugar composition. The set of glycoforms are often 
described as the glycosylation pattern. Glycoform analysis presents a significant challenge; mass 
spectrometry is one of the principal techniques for their analysis [5]. In order to study glycoforms, 
the first step nearly always is enzymatic digestion. Often the sugar chain is cleaved off the peptide 
backbone, resulting in an oligosaccharide mixture [6-9]. An alternative is to cleave the peptide 
chain using proteolytic enzymes (usually trypsin), which results in a peptide/glycopeptide mixture. 
Glycopeptides retain information on both the peptide and the corresponding oligosaccharide 
chains. This approach started to gain importance in recent years [8, 10-13], and presents two 
major advantages: (1) Glycosylation sites and also glycosylation patterns at each site can be 
determined. (2) Protein-specific glycosylation patterns can be determined not only for pure 
glycoprotein samples, but for glycoprotein mixtures as well. This simplifies sample preparation 
significantly, and may allow determining glycosylation patterns of specific glycoproteins in 
complex mixtures (like blood plasma) as well.  
 
Glycopeptides are studied predominantly by mass spectrometry, and this approach has been 
reviewed recently [5, 11]. When using electron capture or electron transfer dissociation (ECD, 
ETD), fragmentation of the peptide backbone is typical, yielding information on the peptide 
sequence and the site of glycosylation. Using collision induced decomposition (CID), fragmentation 
of the oligosaccharide chain takes place, yielding structural information on the oligosaccharide 
unit. Automatic analysis of glycopeptide mass spectra can be facilitated by theoretical spectra 
simulation [14]. A particularly important aspect of glycoprotein analysis is identification and 
quantitation of fucosylation, which may either take place on the antenna, or on the core GlcNAc 
unit. In a recent paper [15] energy resolved mass spectra were studied to confirm fucose-related 
fragmentation processes. This indicated that although fucose is lost easily from glycopeptides in 
CID, but this process is insignificant in single stage mass spectra.  
 
In the present paper we discuss energy resolved CID fragmentation processes of glycopeptides. 
This may help evaluating tandem mass spectra and to select optimum experimental conditions for 
glycopeptide analysis. Here we study N-glycopeptides, although the presented concepts can be 
easily extended to O-glycopeptide fragmentation as well.  
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2) Methods and materials 
 
1.1 Samples, chemicals and sample preparation 
Human alpha-1-acid glycoprotein (AGP) and serotransferin standards was purchased from Sigma-
Aldrich (St. Louis, MO, USA). RapiGest SF (lyophilized sodium-3-[(2-methyl-2-undecyl-1,3-dioxolan-
4-yl)-methoxyl]-1-propane-sulfonate) was obtained from Waters (Milford, MA, USA). Cetuximab 
was obtained from Centocor BV, Hungary. Mass spectrometry grade trypsin (Promega 
Corporation, Madison, WI, USA) was used. All other reagents and enzymes were obtained from 
Sigma-Aldrich (St. Louis, MO, USA). Protein samples were digested by trypsin, according to 
protocols described recently [13]. The resulting peptide/glycopeptide mixtures were separated 
using a nanoflow UHPLC system (nanoAcquity UPLC, Waters, Milford, MA, USA) with reverse 
phase C18 column (BEH, 75 µm x 200 mm) and a 110 min gradient [13].   
 
1.2 Mass spectrometry 
Compounds eluting from the nano-UHPLC were introduced into a high resolution QTOF Premier 
mass spectrometer (Waters, Milford, MA, USA), using electrospray ionization in positive ion mode. 
In order to avoid fragmentation in the ion source, the cone voltage was kept at a low voltage (15 
V). Collision gas was argon, at 4*10-3 mbar; collision voltage was varied in the 0-50 V range to 
obtain energy resolved tandem mass spectra. To obtain good signal-to-noise ratio, MS/MS scan 
time was 2 s, taking several spectra under identical conditions. To obtain energy dependent 
spectra of various charge states of the same compound, mutiple UHPLC runs were performed.  
 
1.3 Glycopeptide terminology 
Nomenclature used for complex oligosaccharides have been reported before [11, 13]. Briefly, all 
glycoforms contain a pentasaccharide core (GlcNAc2Man3) and a number of lactosamine 
(Gal·GlcNAc) antenna (2-4, labelled as Bi, Tri, Tetra). The antenna may be capped by a sialic acid 
unit, ’S’ with the subsequent numeral indicates the number of sialic acid units present (e.g. BiS2). 
The oligosaccharides may contain a fucose unit, its presence is indicated by “F”, like BiS2F1. The 
peptide sequence of the glycopeptide is indicated by the conventional one letter code, e.g. 
BiS2·NEEYNK. 
 
 
3) Results and Discussion 
 
Glycopeptides (like peptides) typically form multiply charged (protonated, occasionally cationized) 
ions under electrospray ionization conditions. The charge state of glycopeptides is somewhat 
lower than that of peptides of similar mass, so they are usually observed at higher m/z ratios. The 
molecular mass of typical N-glycopeptides is in the 3-4000 Da mass range; charge states 2+, 3+ are 
commonly, 4+ occasionally observed. A major feature of glycopeptide fragmentation is, that these 
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compounds require much less energy to fragment than peptides of similar mass to charge ratio. 
This is observed both in single stage [16], and in tandem mass spectra. Fig. 1 shows collision 
energy-dependent (energy resolved) CID spectra of an AGP (alpha-acid-glycoprotein) derived 
glycopeptide, [BiS2·NEEYNK+3H]3+. To observe a similar degree of fragmentation for a triply 
protonated peptide of the same mass would require approximately 3 times higher collision 
energy. The degree of fragmentation can be well described by the relative abundance of the 
molecular signal, which is defined as the survival yield [17], SY=M/(M+F). Here M indicates 
intensity of the molecular ion signal, F the sum of the intensities of all fragment ions. 
“Fragmentation efficiency” is also a commonly used terminology; this defines the relative 
abundance of fragment ions (FE=F/(M+F)=1-SY). Fragmentation efficiency is also used with 
respect to a given fragment ion, in this case FEi=Fi/(M+Fi).  
 
The spectra in Fig. 1 show relatively few fragmentation processes at low, and a large variety of 
fragments at high collision energy. Nearly all cleavages occur at the glycosidic bonds (i.e. between 
sugar residues; and correspond to Y and B type ions [11, 18]. Fragmentation processes can be best 
evaluated at low collision voltage, around 10 V in the present case. (Note, 10 V collision voltage 
corresponds to 30 eV laboratory frame collision energy for a 3+ ion.) The survival yield in this case 
is 60%, the triply protonated molecule being the most abundant peak in the spectrum. The 
internal energy at this collision energy is relatively low, so consecutive fragmentation processes 
(described below) are absent, facilitating spectra evaluation. There is only one small peak in the 
spectrum which corresponds to neutral loss from the precursor ion (sialic acid loss at m/z 904). All 
other ions are formed by charge separation processes [19].  
 
In the course of charge separation the triply protonated molecule breaks up into a singly charged 
and a doubly charged ions. Cleavage at a glycosidic bond forms a singly charged sugar (oxonium) 
ion and a doubly charged counterpart (easiest to describe as “sugar” or “antenna loss”, Fig. 2). The 
doubly charged fragments are easy to identify, as they appear at a higher m/z values than the 
parent triply protonated molecule. Three major fragmentation processes are observed for 
[BiS2·NEEYNK]3+ - these correspond to the loss of a singly charged sialic acid ( [Sia+H]+ ); singly 
charged whole ‘antenna’ ( [Sia·Gal·GlcNAc+H]+ ) and loss of a singly charged larger sugar, ( 
[Sia·Gal·GlcNAc·Man+H]+ ). With very low intensity loss (and formation) of a singly charged 
disaccharide, ( [Sia·Gal+H]+ ) can also be observed. Note, all of these fragments are produced by 
cleavage of a single bond (as indicated in Fig. 2), and represent structural units present in the 
starting compound. The 6 charged products of these three processes give rise to the major 
fragment ions in the 10 V spectrum shown in Fig. 1. Note, although the singly and doubly charged 
complementary fragments should have the same abundance, the observed signals have somewhat 
different abundances, due to differences in mass discrimination and detection efficiency, and due 
to possible secondary processes (at higher energies).  
 
Increasing the collision energy complicates the spectra significantly. At 20 V (Fig. 1) the molecular 
species ([M+3H]3+) practically disappears, while the spectrum becomes dominated by consecutive 
processes. Easiest to identify among these are high mass singly charged ions: These are formed by 
losing a second ‘antenna’ from the doubly charged primary products. The fragmentation scheme 
in Fig. 2 shows these in simplified form; one such reaction cascade is given below:  
[M + 3H]3+  [Sia·Gal·GlcNAc + H]+ + [M – {Sia·Gal·GlcNAc} + 2H]2+ 
     [M – {Sia·Gal·GlcNAc} + 2H]2+  [Sia + H]+ + [M – {Sia·Gal·GlcNAc} - Sia + H]+ 
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Note that the oxonium ion products overlap with those produced by direct cleavages. Larger singly 
charged oxonium ions may also fragment by cleavage of a glycosidic bond, e.g. [Sia·Gal·GlcNAc + 
H]+ may yield [Sia + H]+. Small neutral losses (like water loss from [Sia + H]+) also occur. With some 
exceptions, most high energy fragments may be formed via several reaction channels, and 
therefore have limited utility for structure analysis.  
 
One structurally important fragment observed at high collision energy (20 and 40 V spectra in Fig. 
1) is the peptide chain with one sugar unit attached; observed as a singly charged ion ( 
[Pep·GlcNAc + H]+, which may also be described as the Y1 ion [11]). This has high relevance for 
structure analysis, as this ion clearly indicates the mass of the peptide chain (and therefore can be 
used to identify which glycoprotein gives rise to the studied glycopeptide) [13, 20]. This ion may 
fragment further loosing the last GlcNAc unit, yielding a singly protonated peptide ion ( [Pep + H]+ 
). Another useful feature of high energy spectra are the abundant oxonium ions. Observing several 
oxonium ions in an MS/MS spectrum is clear indication that the studied compound contains an 
oligosaccharide chain (in a tryptic digest this clearly identifies a glycopeptide).  
 
Energetics of fragmentation can be described in a quantitative manner using breakdown diagrams. 
These show the relative abundance of various fragments (F/M+F) as a function of collision 
voltage. As described above, we use ‘collision voltage’ and not the more commonly used 
terminology ‘collision energy’ for two reasons: First, this clearly indicates the laboratory and not 
the center-of-mass frame of reference. Second, for multiply charges species the collision energy is 
obtained by multiplying the collision voltage and the charge state. Using ‘collision voltage’ makes 
it easier to relate results to experimental parameters, and avoids ambiguity. Note also, that the 
collision voltage, laboratory and center-of-mass collision energies are all linearly related.  
 
The breakdown diagram of [BiS2·NEEYNK]3+ is shown in Fig. 3a (see also the spectra in Fig. 1). For 
clarity only a few selected fragmentation processes are included. The complementary charge 
separation fragments of [Sia·Gal·GlcNAc + H]+ and [M – {Sia·Gal·GlcNAc} + 2H]2+ ions and also 
neutral sialic acid loss are all formed at low collision voltage, and their intensity passes through a 
maximum around 15 V. Other primary charge separation processes show similar energy 
dependence. Energy dependence of these processes is better illustrated in Fig. 3b, where the 
breakdown diagram is normalized to the respective ion abundances observed at 10 V collision 
voltage. Fig. 3b clearly indicates similar energy dependence for all primary fragmentation 
processes at low collision voltages. This strongly suggests that the activation energies of these 
processes are also similar.  
 
Above ca. 15 V most of these ions start to decompose, as indicated by decreasing intensities in Fig. 
3b (also evident in Fig. 3a). Doubly charged products fragment by charge separation reactions (as 
described above), while singly charges oligosaccharide oxonium ions fragment to yield smaller 
sugar fragments. The energy onset of these secondary processes can be well illustrated in Fig. 3c, 
in which case ion abundances are normalized to that observed at 30 V collision voltage.  
 
The similar behavior of fragmentation efficiency curves shown in Fig. 3 suggests, that the cleavage 
of various glycosidic bonds requires similar activation energies. Both the formation and 
fragmentation of the large oligosaccharide oxonium ion [Sia·Gal·GlcNAc·Man + H]+ at m/z 819 is 
somewhat easier than that of other oxonium ions, best illustrated in Fig. 3b. On the other hand 
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cleavage between Gal and GlcNAc units on the antennae produces very small ion signals; 
suggesting that this reaction requires somewhat higher activation energy. Cleavage between Man 
and GlcNAc on the oligosaccharide core has not been observed, suggesting that this reaction is 
unfavorable, either due to energetic or steric effects.  
 
At this point it is interesting to compare these results to the energy resolved studies obtained by Y. 
Wada [15]. In many respects the results are analogous, but there are some differences as well. 
First, results presented here show several abundant processes at low energy, and not only that of 
[Sia·Gal·GlcNAc + H]+ formation. Second, in our case not only the singly charged oxonium ions (i.e. 
Bn ions), but the complementary high mass fragments (e.g. [M – {Sia·Gal·GlcNAc} + 2H]
2+) 
fragments were also observed. Absence of these higher mass ions is likely due to discrimination 
effects in the ion trap instrument. Note that formation of a singly charged product from a triply 
charged ion must be accompanied by formation of a doubly charged ion; and such fragments were 
observed before [14].  
 
Another important aspect of glycopeptide fragmentation is the influence of the charge state. This 
has been studied in a number of cases, and all showed analogous behavior. As example, Fig. 4 
shows the survival yield curves of 2+, 3+ and 4+ charge states of a glycopeptide, 
TriS3·LVPVPITNATLDR (doubly, triply and quadruply protonated molecules, respectively). The 
Figure clearly shows that high charge states fragment at much lower voltages, than low charge 
states. Collision voltages corresponding to SY50 of the three charge states are 39, 17.5 and 8.5 V, 
respectively. A major part of this difference is simply due to the fact, that the collision energy of an 
ion is directly proportional to the number of charges. In the present case the (laboratory frame) 
collision energies are 78, 52 and 34 eV, respectively. These values show that high charge states not 
only fragment at lower voltages, but also at lower collision energies. This in turn indicates, that the 
activation energy of fragmentation of high charge states is lower (or much lower) than those of 
low charge states. This is easily explained, as charge repulsion increases with the number of 
charges on the molecule; and as part of the charge repulsion is used to decrease the activation 
energy of charge separation processes [21]. As described above, glycopeptide fragmentation 
mainly proceeds by charge separation, so this effect decreases the activation energy of most 
processes.  
 
Neutral losses are not affected by charge repulsion, so the activation energy of these processes is 
similar for all charge states. Spectra shown in Fig. 1 indicate that loss of a neutral sialic acid and 
the primary charge separation processes requires similar activation energy for the 3+ ion. This 
should imply, that neutral losses should be more pronounced for 2+ than for 3+ or 4+ ions. The 
mass spectra of doubly, triply and quadruply protonated TriS3·LVPVPITNATLDR (m/z 2135, 1424, 
and 1068) does indeed show this effect (Fig. 5): At a collision voltage corresponding to 50% 
survival yield of [TriS3·LVPVPITNATLDR + 2H]2+ neutral sialic acid loss (m/z 1990) is one of the most 
abundant fragments; in the spectrum of the triply protonated compound it is a small, but clearly 
observable ion; while in the case of the quadruply protonated ion it cannot be observed. In other 
respects the fragmentation patterns of various protonated forms are analogous; and follow the 
pattern discussed in detail for the BiS2 glycoform (Figs. 1, 2 and 3). Not counting small neutral 
losses, fragmentation commences with a charge separation cleavage of a glycosidic bond. In the 
case of the doubly and triply protonated ion the most abundant is the [Sia·Gal·GlcNAc + H]+ (m/z 
657). In the case of double protonated species the complementary [M – {Sia·Gal·GlcNAc} + H]+ is 
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observed at m/z 3615 (shown in Fig. 5a). For the triply protonated compound the complementary 
[M – {Sia·Gal·GlcNAc} + 2H]2+ product is a large peak (at m/z 1808). In the case of the quadruply 
protonated species both analogous products [Sia·Gal·GlcNAc + H]+ and [M – {Sia·Gal·GlcNAc} + 
3H]3+ (m/z 1205) can be observed, but their intensity is significantly reduced. Another glycosidic 
cleavage leads to production of [Sia + H]+ (m/z 292) and complementary [M - Sia + nH]n+ ions. This 
leads to small ions in the case of double and triple protonation, but is the predominant process for 
the quadruply protonated molecule (Fig. 5c). Differences in relative abundances of [Sia + H]+ and 
[Sia·Gal·GlcNAc + H]+ formation among different charge states are reasonable to explain based on 
charge repulsion. The most likely (energetically most favourable) protonation site is a GlcNAc unit, 
resulting in preferential cleavage beside GlcNAc and Man, leading to [Sia·Gal·GlcNAc + H]+ 
formation [15]. When there are many (four) charges (protons) in a molecule, charge repulsion 
shifts the most likely protonation site towards the end of the molecule, i.e. to the sialic acid units. 
This results in preferential [Sia + H]+ (and [M – Sia + 3H]3+ ) formation in the quadruply protonated 
species. The third type of glycosidic bond cleavage observed for BiS2 glycoform, cleavage between 
the core mannose units, are also found in TriS3. However, due to sensitivity reasons, the products 
were observed only for the triply protonated ions. For the doubly charged ions neutral losses, for 
the 4+ species preferential [Sia + H]+ formation dominates, as discussed above. Increasing the 
collision energy consecutive reactions start to appear, just as in the case shown in Fig. 1. These 
eventually lead to singly charged mono and oligosaccharides (oxonium ions) and to the [Pep + 
GlcNAc]+ and [Pep]+ fragments. Fragmentation of other glycopeptides follows the same rules as 
described above. The peptide chain influences fragmentation only to a minor degree; collision 
energy dependence and fragmentation of the oligosaccharide chain is closely analogous to that 
discussed for the BiS2 and TriS3 glycoforms discussed in detail above.  
 
Fucose containing glycopeptides have been studied by Y. Wada [15], indicating that (a) these 
compounds preferentially loose fucose in CID but (b) can be quantitated under low energy 
conditions (in which case there is no fragmentation). These findings are analogous to our energy 
resolved studies on sialylated glycoforms [16]. Energy-resolved fragmentation characteristics of 
glycopeptides, as discussed above, can be used to distinguish (identify) antenna (1,3/4) and core 
(1,6) fucosylated glycoforms. Fig. 6a and b shows the low energy (SY50) spectra of triply 
protonated BiS2F1·NEEYNK and TriS3F1·LVPVPITNATLDR glycopeptides; where annotation of the 
major components are also indicated. These are fucosylated analogs of the BiS2 and TriS3 
glycoforms shown in Fig. 1b and 5b; fragmentation processes are analogous, even ion abundances 
are similar. Both glycoforms are derived from human AGP; fucose is known to be located on the 
antenna. The presence of fucose opens up the possibility of neutral fucose loss [15], which yields 
ions of similar abundance to that of neutral sialic acid loss. In the 3+ species both are small peaks 
(ca. 5% of the total fragment ion abundance); analytically these are not useful. Structurally most 
indicative are the peaks due to primary charge separation process leading to [Sia·Gal·GlcNAc·Fuc + 
H]+ and [M – {Sia·Gal·GlcNAc·Fuc} + 2H]2+ (loss of a fucosylated antenna). Presence of these peaks 
can only be explained by fucosylation on the antenna; observing both peaks provides further 
confirmation. Both peaks are abundant, their intensity is somewhat smaller than those of the 
[Sia·Gal·GlcNAc·Fuc + H]+ and [M – {Sia·Gal·GlcNAc·Fuc} + 2H]2+ (which structural units are also 
present in the compound). A medium and high energy the spectra show the [Pep·GlcNAc]+ ion; but 
no signals are observed due to [Pep·GlcNAc·Fuc]+; confirming that there is no core-fucosylation 
(spectra are not shown).  
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Core fucosylation, on the other hand, is evident in the spectrum of the 
BiS2F1·QQQHLFGSNVTDCSGNFCLFR glycoform (derived from human transferrin). The spectrum in 
insert of Fig. 6c shows both [Pep·GlcNAc + 2H]2+ and [Pep·GlcNAc·Fuc + 2H]2+ ions in approximately 
1:1 ratio; indicating fucosylation on the core GlcNAc unit. The low mass primary fragment 
[Sia·Gal·GlcNAc + H]+ is a major peak in the spectrum, while only traces of [Sia·Gal·GlcNAc·Fuc + 
H]+ are observed (signal intensity is only 3% that of [Sia·Gal·GlcNAc + H]+). This suggests that 
antenna fucosylation is present in very small amounts in this ion. Comparing signal intensities in 
Fig. 6a b and c suggests that BiS2F1·QQQHLFGSNVTDCSGNFCLFR contains ca. 5-10% antenna and 
90-95% core fucosylation. The last example is GlcNAc4Man3·EEQYNSTYR glycopeptide, derived a 
pharmaceutical antibody, Cetuximab. This contains two truncated antennas, the low energy 
spectrum of the doubly protonated glycopeptide is shown in Fig. 6d. Fragmentation is analogous 
to that of other glycopeptides discussed above. The largest fragment peak in the spectrum 
corresponds to a charge separation process leading to ‘antenna loss’ – as the compound contains 
a truncated antenna, this is a monosaccharide unit, [GlcNAc + H]+. The corresponding 
complementer ion, [M – GlcNAc+H]+ is also visible at m/z 2431 as a low intensity peak.  Traces of 
the fucosylated antenna [GlcNAc·Fuc + H]+ can also be observed, but abundance of this peak is 
only 5% that of [GlcNAc + H]+. On the other hand, both [Pep·GlcNAc]+ and [Pep·GlcNAc·Fuc]+ ions 
are observed; their abundance ration is approximately 1:1 ratio, like in the case of transferrin (Fig. 
6c). This indicates, that Cetuximab is predominantly core fucosylated [22, 23]; antenna 
fucosylation is present in very small (very approximately 10%) amount.  
 
 
4) Conclusions 
 
Energy-resolved CID spectra of glycopeptides show a number of important features. This 
information on fragmentation mechanism can be well utilized for practical applications and for 
glycoprotein analysis:  
1) Fragmentation starts with competing cleavages of glycosidic bonds. These are charge 
separation processes, each yielding a singly charged B-type sugar fragment (oxonium ion) 
and a complementary high mass product. Activation energies of these alternative 
cleavages are close to each other, as shown by their similar increase at low collision voltage 
(Fig. 3b). Activation energies decrease with increasing charge state, and are much lower 
than those corresponding to peptide fragmentation. Optimum collision voltage for 
glycopeptides is 3-5 times lower than that typically used for peptides of the same mass and 
charge state.  
2) Second generation products are also formed by glycosidic bond cleavages; the collision 
voltage necessary to induce these processes is approximately two times higher than that 
needed for the first cleavage process (compare Fig. 3b and c). These secondary processes 
create a multitude of fragments and alternative reaction sequences and, in practice, are 
difficult to evaluate. An important secondary process, however, is formation of the 
[Pep·GlcNAc]+ fragment (the Y1 ion).  
3) Neutral monosaccharide losses (B type cleavages, but with proton transfer to yield a small 
neutral sugar fragment) often take place from multiply protonated molecules. Sugar losses 
take place only from the ends of the oligosaccharide chains – i.e. mostly silalic acid or 
fucose (if present in the molecule). Glycopeptides with truncated antenna may loose the 
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monosaccharide from the end of the chain (e.g. neutral GlcNAc loss from 
GlcNAc4Man3·EEQYNSTYR peptide of Cetuximab, Fig. 6d). These processes are abundant 
only in lower charge states (doubly protonated molecules), and do not provide much 
structural information.  
4) Spectrum analysis at low collision voltage, that corresponding to about 50% survival yield, 
provides important advantages. This is below the onset of consecutive reactions (Fig. 3); so 
spectra are easier to evaluate, and fragments can be directly related to the structure of the 
oligosaccharide. In most cases fragmentation of triply protonated molecules give best 
results; cleavage of the antenna between GlcNAc and Man is usually the most abundant 
process. Higher charge states are dominated by sialic acid formation; while in low charge 
states neutral losses predominate.  
5) The fucosylation site can be determined from fragmentation. Antenna fucosylation in most 
human proteins corresponds to the presence of immunologically important Lewis-X (or 
sialylated Lewis X) antigen. Presence or absence of antenna fucosylation is clearly indicated 
in the low energy spectrum by observing the singly charged antenna – [Sia·Gal·GlcNAc + H]+ 
at m/z 657 and [Sia·Gal·GlcNAc·Fuc + H]+ at m/z 803. In antenna fucosylated glycoform the 
abundance ratio of m/z 803/657 is approximately 30-50% (Fig. 6a and b, but observed in 
several other cases as well). In the case of de-sialylated compounds or compounds with 
truncated antenna, analogous ion ratios may be observed. Core fucosylation is indicated by 
the presence of [Pep·GlcNAc·Fuc]+; which has a similar abundance to that of [Pep·GlcNAc]+.  
6) High energy spectra, obtained at 2-4 times higher voltage than that corresponding to 50% 
survival yield are often useful to identify the [Pep·GlcNAc] fragment, and therefore the 
mass of the peptide chain. Such high energy spectra are also useful to identify low mass 
oxonium ions, which can be identified reliably even if the signal to noise ratio of the 
tandem mass spectrum is very low. This can be used to confirm, that the studied ion 
corresponds to a glycopeptide.  
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7) Figure Captions 
 
Fig. 1. Energy resolved tandem mass spectra of the triply protonated [BiS2·NEEYNK]3+ glycopeptide 
derived from AGP. Spectra were obtained at 0, 10, 20 and 40 V collision voltage. The spectrum at 
low voltage shows mainly direct fragmentation of the triply protonated molecule, while at higher 
energies products of consecutive reactions dominate the spectra. See text for details.  
 
Fig. 2. Fragmentation scheme of BiS2 type glycopeptides. All primary, and a few selected 
consecutive reaction processes are shown. Fragmentation of glycopeptides with different sugar 
chains is analogous. 
 
Fig·3. Breakdown diagrams of [BiS2·NEEYNK]3+ showing selected fragmentation processes. (a) 
Conventional format, showing fragmentation processes and the survival yield curve in different 
scales. (b) Breakdown diagram showing some first generation product ions, renormalized to 
intensity observed at 10V collision voltage. This shows that at low energy intensity of all these 
processes increase with collision voltage at a similar rate. At higher voltages secondary processes 
change intensities at a different rate. (c) Breakdown diagram showing selected second generation 
fragments. This shows that these processes have approximately similar onset energies.  
 
Fig. 4. Survival yield curves of the TriS3·LVPVPITNATLDR glycopeptide; observed for the 2+, 3+ and 
4+ charge states (2, 3 and 4-times protonated forms).  
 
Fig. 5. Tandem mass spectra of doubly, triply and quadruply protonated TriS3·LVPVPITNATLDR 
glycopeptide, derived from AGP. All spectra correspond to ca. 50% survival yield; and have been 
taken at 35 V, 15 V and 7 V collision voltage. Fragmentation is discussed in detail in the text. 
 
Fig. 6. Low energy CID spectra of selected glycopeptides, containing a fucose residue. See text for 
discussion.  (a) TriS3F1·LVPVPITNATLDR, (b) BiS2F1·NEEYNK, (c) 
BiS2F1·QQQHLFGSNVTDCSGNFCLFR, (d) N4H3S0F1·EEQYNSTYR  
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derived from AGP. Spectra were obtained at 0, 10, 20 and 40 V collision voltage. The spectrum at 
low voltage shows mainly direct fragmentation of the triply protonated molecule, while at higher 
energies products of consecutive reactions dominate the spectra. See text for details.  
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Fig. 2. Fragmentation scheme of BiS2 type glycopeptides. All primary, and a few selected 
consecutive reaction processes are shown. Fragmentation of glycopeptides with different sugar 
chains is analogous.  
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Fig·3. Breakdown diagrams of [BiS2·NEEYNK]3+ showing selected fragmentation processes. (a) 
Conventional format, showing fragmentation processes and the survival yield curve in different 
scales. (b) Breakdown diagram showing some first generation product ions, renormalized to 
intensity observed at 10V collision voltage. This shows that at low energy intensity of all these 
processes increase with collision voltage at a similar rate. At higher voltages secondary processes 
change intensities at a different rate. (c) Breakdown diagram showing selected second generation 
fragments. This shows that these processes have approximately similar onset energies.  
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Fig. 4. Survival yield curves of the TriS3·LVPVPITNATLDR glycopeptide; observed for the 2+, 3+ and 
4+ charge states (2, 3 and 4-times protonated forms).  
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Fig. 5. Tandem mass spectra of doubly, triply and quadruply protonated TriS3·LVPVPITNATLDR 
glycopeptide, derived from AGP. All spectra correspond to ca. 50% survival yield; and have been 
taken at 35 V, 15 V and 7 V collision voltage. Fragmentation is discussed in detail in the text. 
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1.  
Fig. 6. Low energy CID spectra of selected glycopeptides, containing a fucose residue. See text for 
discussion.  (a) TriS3F1·LVPVPITNATLDR, (b) BiS2F1·NEEYNK, (c) 
BiS2F1·QQQHLFGSNVTDCSGNFCLFR, (d) N4H3S0F1·EEQYNSTYR  
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